Literature DB >> 16083074

Blastocystis hominis among symptomatic and asymptomatic individuals in Talkha Center, Dakahlia Governorate, Egypt.

Atef M El-Shazly1, Aida A Abdel-Magied, Samar N El-Beshbishi, Hala A El-Nahas, Mahmoud A H Fouad, Mohamed S M Monib.   

Abstract

Blastocystis hominis is now getting acceptance as an agent of human intestinal disease. B. hominis in stool samples of symptomatic and asymptomatic individuals was evaluated as a possible cause of gastro-intestinal troubles. B. hominis was found in 106 (10.1%) out of 1050 individuals examined from six villages and one city in Talkha Center, Dakahlia Governorate. The highest infection rate was in Manshayt El-Badawy village (25.47%), whereas Talkha City showed the lowest rate (4.73%). Age group 10-20 years had higher infection (13.3%). In twenty-three symptomatic patients, B. hominis represented the only causative parasitic agent. The most common symptoms were diarrhoea (30.4%), abdominal pain (26.1%), flatulence (21.7%). vomiting (13.1%) and fatigue (8.7%). High concentrations of B. hominis were found in symptomatic patients than in asymptomatic ones with statistical significant difference (8.2 cells/100 x field versus 3.8 respectively). The mean number of B. hominis was significantly high in patients complaining of diarrhoea and abdominal pain.

Entities:  

Mesh:

Year:  2005        PMID: 16083074

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  12 in total

1.  Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal.

Authors:  I L Lee; T C Tan; P C Tan; D R Nanthiney; M K Biraj; K M Surendra; K G Suresh
Journal:  Parasitol Res       Date:  2011-11-11       Impact factor: 2.289

2.  Prevalence and Clinical Features of Blastocystis hominis Infection among Patients in Sebha, Libya.

Authors:  Mohammed A Al-Fellani; Abdul H Khan; Rugaia M Al-Gazoui; Mabrouk K Zaid; Mahmoud A Al-Ferjani
Journal:  Sultan Qaboos Univ Med J       Date:  2007-04

Review 3.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner.

Authors:  Manoj K Puthia; Jia Lu; Kevin S W Tan
Journal:  Eukaryot Cell       Date:  2007-12-21

5.  Cross-sectional surveys and subtype classification of human Blastocystis isolates from four epidemiological settings in China.

Authors:  Lan Hua Li; Xiao Ping Zhang; Shan Lv; Ling Zhang; Hisao Yoshikawa; Zhiliang Wu; Peter Steinmann; Jürg Utzinger; Xiao Mei Tong; Shao Hong Chen; Xiao Nong Zhou
Journal:  Parasitol Res       Date:  2007-10-02       Impact factor: 2.289

6.  Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116.

Authors:  Samudi Chandramathi; Kumar Suresh; Umah Rani Kuppusamy
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

7.  Clinical significance and prevalence of Blastocystis hominis in Van, Turkey.

Authors:  Yunus E Beyhan; Hasan Yilmaz; Zeynep T Cengiz; Abdurrahman Ekici
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

8.  Predominance of Blastocystis sp. Infection among School Children in Peninsular Malaysia.

Authors:  Kalimuthu Nithyamathi; Samudi Chandramathi; Suresh Kumar
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

9.  Prevalence, predictors and clinical significance of Blastocystis sp. in Sebha, Libya.

Authors:  Awatif M Abdulsalam; Init Ithoi; Hesham M Al-Mekhlafi; Abdul Hafeez Khan; Abdulhamid Ahmed; Johari Surin; Joon Wah Mak
Journal:  Parasit Vectors       Date:  2013-04-08       Impact factor: 3.876

10.  Prevalence and Genotype Characterization of Blastocystis hominis Among the Baghmalek People in Southwestern Iran in 2013 - 2014.

Authors:  Saleh Khoshnood; Abdollah Rafiei; Jasem Saki; Kobra Alizadeh
Journal:  Jundishapur J Microbiol       Date:  2015-10-18       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.